The store will not work correctly when cookies are disabled.
2,4'-Bipyridin-3-yl(4-hydroxy-4-(pyridin-2-ylmethyl)piperidin-1-yl)methanone
ID: ALA5269664
Max Phase: Preclinical
Molecular Formula: C22H22N4O2
Molecular Weight: 374.44
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccn2)CC1
Standard InChI: InChI=1S/C22H22N4O2/c27-21(19-5-3-11-25-20(19)17-6-12-23-13-7-17)26-14-8-22(28,9-15-26)16-18-4-1-2-10-24-18/h1-7,10-13,28H,8-9,14-16H2
Standard InChI Key: CFUZDIHJEMMDOQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
6.1789 -16.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1777 -16.8662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8905 -17.2779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6049 -16.8657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6021 -16.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8887 -15.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8922 -18.0984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1780 -18.5089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1775 -19.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8903 -19.7432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6053 -19.3276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6023 -18.5070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4649 -17.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4642 -18.0996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7528 -16.8651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7529 -16.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0448 -15.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3296 -16.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3270 -16.8572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0395 -17.2736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6191 -15.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9047 -16.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1947 -15.6145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4808 -16.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4766 -16.8455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1922 -17.2600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9031 -16.8502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3217 -15.2101 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
2 13 1 0
13 14 2 0
13 15 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
18 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
18 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 374.44 | Molecular Weight (Monoisotopic): 374.1743 | AlogP: 2.75 | #Rotatable Bonds: 4 |
Polar Surface Area: 79.21 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.21 | CX LogP: 0.94 | CX LogD: 0.93 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.76 | Np Likeness Score: -1.00 |
References
1. Koike T, Yoshikawa M, Ando HK, Farnaby W, Nishi T, Watanabe E, Yano J, Miyamoto M, Kondo S, Ishii T, Kuroita T.. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)., 64 (16.0): [PMID:34387987] [10.1021/acs.jmedchem.1c00864] |